S1701, A Randomized Phase 2 Trial of Carboplatin-Paclitaxel With and Without Ramucirumab in Patients With Locally Advanced, Recurrent, or Metastatic Thymic Carcinoma by Tsao, Anne S., MD, MBA, Hsieh, Ming-Hui, MS, Koczywas, Marianna, MD, Tu, Janet, MD, Riess, Jonathan, MD, MS, Tanvetyanon, Tawee, MD, Ma, Barbara T., MD, Zhao, Ying-Qi, PhD, Redman, Mary W., PhD, Edelman, Martin J., MD, Gandara, David R., MD, Gray, Jhanelle E., MD, Kelly, Karen L., MD

Get full text

Cetuximab plus carboplatin and paclitaxel with or without bevacizumab versus carboplatin and paclitaxel with or without bevacizumab in advanced NSCLC (SWOG S0819): a randomised, ph... by Herbst, Roy S, MD, Redman, Mary W, PhD, Kim, Edward S, MD, Semrad, Thomas J, MD, Bazhenova, Lyudmila, MD, Masters, Gregory, MD, Oettel, Kurt, MD, Guaglianone, Perry, MD, Reynolds, Christopher, MD, Karnad, Anand, MD, Arnold, Susanne M, MD, Varella-Garcia, Marileila, PhD, Moon, James, MS, Mack, Philip C, PhD, Blanke, Charles D, MD, Hirsch, Fred R, MD, Kelly, Karen, MD, Gandara, David R, MD

Get full text

Biomarker-driven therapies for previously treated squamous non-small-cell lung cancer (Lung-MAP SWOG S1400): a biomarker-driven master protocol by Redman, Mary W, Prof, Papadimitrakopoulou, Vassiliki A, Prof, Minichiello, Katherine, MS, Hirsch, Fred R, Prof, Mack, Philip C, PhD, Schwartz, Lawrence H, Prof, Vokes, Everett, Prof, Ramalingam, Suresh, Prof, Leighl, Natasha, MD, Bradley, Jeff, Prof, Miao, Jieling, MS, Moon, James, MS, Highleyman, Louise, BS, Miwa, Crystal, BS, LeBlanc, Michael L, Prof, Malik, Shakun, MD, Miller, Vincent A, MD, Sigal, Ellen V, PhD, Adam, Stacey, PhD, Wholley, David, MS, Sigman, Caroline, PhD, Smolich, Beverly, PhD, Blanke, Charles D, Prof, Kelly, Karen, Prof, Gandara, David R, Prof, Herbst, Roy S, Prof

Get full text